A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophyNathalie Goemans, Yasuhiro Takeshima, Alberto Dubrovsky et al.|Neuromuscular Disorders|2017Cited by 128
Genetic testing in children enrolled in epilepsy surgery program. A real-life studyBarbora Straka, Pavel Kršek, Barbora Splítková et al.|European Journal of Paediatric Neurology|2023Cited by 20